GlassScriptPhysician profile
Neel H Patel
NPI 1811302896
$2,118.32
in general payments reported to CMS, 2019-2025
21 companies · $591 in 2025
The $591 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2022: $70.61 · 2023: $391 · 2024: $760 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,674 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,674.42 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $215.56 | 2024-2025 | Barrigel |
| Globus Medical, INC. | $199.36 | 2019 | |
| Boston Scientific Corporation | $178.38 | 2022-2025 | Lithovue, Spaceoar System |
| Urogen Pharma, INC. | $159.19 | 2025 | |
| Bioventus LLC | $156.59 | 2023-2024 | Bonescalpel, Nexus-10 Mkii |
| Alphatec Spine, INC | $153.81 | 2023 | |
| Procept Biorobotics Corporation | $142.49 | 2024 | Aquabeam System |
| Coloplast Corp | $135.63 | 2024 | |
| Janssen Biotech, INC. | $113.39 | 2024-2025 | Erleada, Simponi Aria, Stelara |
| Integra Lifesciences Corporation | $107.10 | 2023 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Stryker Corporation | $105.93 | 2019 | |
| Pfizer INC. | $95.40 | 2024-2025 | |
| 180 Medical, INC. | $92.34 | 2024-2025 | |
| Axonics, INC. | $78.26 | 2024 | Axonics |
| Civco Medical Instruments | $38.69 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $36.22 | 2025 | |
| Novartis Pharmaceuticals Corporation | $33.08 | 2024-2025 | |
| Astellas Pharma US INC | $30.27 | 2024-2025 | Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $16.61 | 2024 | |
| Tolmar, INC. | $16.38 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.64 | 2024 | Trulance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neel Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.